Location History:
- Dettelbach, DE (2003)
- Steinen, DE (2008)
Company Filing History:
Years Active: 2003-2008
Title: The Innovations of Kai Blumbach
Introduction
Kai Blumbach is a notable inventor based in Dettelbach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his work on triazole compounds. With a total of 4 patents to his name, Blumbach's innovations are paving the way for advancements in medical treatments.
Latest Patents
One of his latest patents is focused on triazole compounds and their therapeutic use. This invention relates to triazole compounds of general formula (I), wherein A, B, R, R, R, and R have specific meanings as cited in claim 1. The invention also encompasses a pharmaceutical agent that contains at least one compound of general formula (I). This compound is intended for use in treating illnesses that respond to the effects of dopamine-D-receptor antagonists or agonists, particularly for disorders affecting the central nervous system. Another significant patent involves triazole compounds with dopamine-D3-receptor affinity, further showcasing his expertise in this area.
Career Highlights
Throughout his career, Kai Blumbach has worked with prominent companies such as Abbott Laboratories Corporation and Abbott GmbH & Co. KG. His experience in these organizations has contributed to his understanding and development of innovative pharmaceutical solutions.
Collaborations
Blumbach has collaborated with several professionals in his field, including Dorothea Starck and Liliane Unger. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.
Conclusion
Kai Blumbach's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work on triazole compounds is particularly noteworthy, as it holds promise for treating various central nervous system disorders.